Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Malignant Melanoma

  Free Subscription


Articles published in Cutis

Retrieve available abstracts of 29 articles:
HTML format



Single Articles


    January 2024
  1. MANIACI JL, Raghavan SS
    PRAME Expression in Melanocytic Proliferations in Special Sites.
    Cutis. 2024;113:43-47.
    PubMed     Abstract available


    November 2023
  2. WHITE KD, Kerkvliet AM, Jassim AD
    Aberrant Expression of CD56 in Metastatic Malignant Melanoma.
    Cutis. 2023;112:E13-E15.
    PubMed    


  3. SHAFI S, Challa B, Parwani AV, Aung TN, et al
    New Therapies in Melanoma: Current Trends, Evolving Paradigms, and Future Perspectives.
    Cutis. 2023;112:E32-E39.
    PubMed     Abstract available


    September 2023
  4. BORMANN JL, Kerkvliet AM
    Granulomatous Dermatitis in a Patient With Cholangiocarcinoma Treated With BRAF and MEK Inhibitors.
    Cutis. 2023;112:E17-E20.
    PubMed    


    May 2023
  5. SULLIVAN DY, Sakamoto GK
    Eruptive Keratoacanthomas After Nivolumab Treatment of Stage III Melanoma.
    Cutis. 2023;111:E13-E15.
    PubMed    


  6. ANDERSON JM, Tejani I, Jarmain T, Kellett L, et al
    Artificial Intelligence vs Medical Providers in the Dermoscopic Diagnosis of Melanoma.
    Cutis. 2023;111:254-258.
    PubMed     Abstract available


  7. MASSON R, Kwong A, Chen A, Barajas G, et al
    Disparities in Melanoma Demographics, Tumor Stage, and Metastases in Hispanic and Latino Patients: A Retrospective Study.
    Cutis. 2023;111:245-246.
    PubMed    


  8. NGO BT
    Gene Expression Profiling for Melanoma Prognosis: Going Beyond What We See With Our Eyes.
    Cutis. 2023;111:222-223.
    PubMed    


  9. LOGAN S, Shinohara MM
    Acral Necrosis After PD-L1 Immune Checkpoint Inhibitor Therapy.
    Cutis. 2023;111:E16-E17.
    PubMed    


    April 2023
  10. KIPERS TG, Mullen HEK, Blumetti B
    Acute Onset of Vitiligolike Depigmentation After Nivolumab Therapy for Systemic Melanoma.
    Cutis. 2023;111:E15-E18.
    PubMed    


    March 2023
  11. LY S, Rollins B, Mohr K, Jennings T, et al
    Hair Repigmentation as a Melanoma Warning Sign.
    Cutis. 2023;111:E18-E21.
    PubMed    


    January 2023
  12. SABLE KA, Shields BE
    The Role of Dietary Antioxidants in Melanoma and Nonmelanoma Skin Cancer.
    Cutis. 2023;111:33-48.
    PubMed     Abstract available


    November 2022
  13. COKER HB 4TH, Mountcastle EA
    Primary Malignant Melanoma of the Middle Ear.
    Cutis. 2022;110:E12-E14.
    PubMed    


    October 2022
  14. ALBERT NM, Gaddi A, Klawonn MA, Helm L, et al
    Genital Lentiginosis: A Benign Pigmentary Abnormality Often Raising Concern for Melanoma.
    Cutis. 2022;110:E36-E38.
    PubMed    


    September 2022
  15. PATEL K, Sanchez IM, Nguyen JC, Chan LS, et al
    Disparities of Cutaneous Malignancies in the US Military.
    Cutis. 2022;110:132-136.
    PubMed     Abstract available


  16. LALLA SC, Kumar AB, Lehman JS, Lohse CM, et al
    Association of BRAF V600E Status of Incident Melanoma and Risk for a Second Primary Malignancy: A Population-Based Study.
    Cutis. 2022;110:150-154.
    PubMed     Abstract available


    August 2022
  17. SAX J, Lamerson C
    Ultra-Late Cutaneous Melanoma Recurrence Following 49 Years of Quiescence.
    Cutis. 2022;110:E53-E55.
    PubMed    


    May 2022
  18. USATINE RP, Heath CR
    Melanoma.
    Cutis. 2022;109:284-285.
    PubMed    


  19. HENRY W, Nash S, Pemberton J
    Conjunctival Melanoma of the Left Lower Eyelid.
    Cutis. 2022;109:E25-E27.
    PubMed    


  20. KARAARSLAN I, Ozdemir F, Yaman B, Acar A, et al
    Reflectance Confocal Microscopy Findings in a Small-Diameter Invasive Melanoma.
    Cutis. 2022;109:269-271.
    PubMed     Abstract available


  21. HARVEY JA, Lehman JS, Lohse CM, Chamberlain AM, et al
    BRAF V600E Expression in Primary Melanoma and Its Association With Death: A Population-Based, Retrospective, Cross-Sectional Study.
    Cutis. 2022;109:279-283.
    PubMed     Abstract available


    June 2021
  22. FAWAZ B, Halpern A
    Nivolumab-Induced Granuloma Annulare.
    Cutis. 2021;107:E2-E4.
    PubMed     Abstract available


    May 2021
  23. STOKAR E, Rodriguez C, Feldman J
    Desmoplastic Melanoma Masquerading as Neurofibroma.
    Cutis. 2021;107:258-260.
    PubMed     Abstract available


  24. TSCHEN J, Davies P, Meek SM, Clarke LE, et al
    Clinical Use of a Diagnostic Gene Expression Signature for Melanocytic Neoplasms.
    Cutis. 2021;107:264-269.
    PubMed     Abstract available


    April 2021
  25. ELIAS ML, John AM, Maddukuri S, Schwartz RA, et al
    Treatment Delay in Melanoma: A Risk Factor Analysis of an Impending Crisis.
    Cutis. 2021;107:E19-E26.
    PubMed     Abstract available


  26. KORNREICH D, Saedi N
    Home Treatment of Presumed Melanocytic Nevus With Frankincense.
    Cutis. 2021;107:E56-E57.
    PubMed    


    January 2021
  27. GALL R, Bongiorno M, Handfield K
    Skin cancer in the US Military.
    Cutis. 2021;107:29-33.
    PubMed     Abstract available


    November 2020
  28. HAMIDI S, Kim GH, DeClerck BK
    Multiple glomangiomas in a patient with a history of metastatic melanoma.
    Cutis. 2020;106:E20-E22.
    PubMed    


    January 2020
  29. CONDIE D, Fathi R, Nijhawan RI
    Cartilage sutures for a large nasal defect.
    Cutis. 2020;105:44-45.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.